Sign In   |   Register
News: Congress

Interview with Professor Steve Nicholls

Monday 30 May 2016  
Share |

Professor Steve Nicholls, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia discusses the ACCENTUATE trial  with evacetrapib, and what the findings mean for ACCELERATE and cholesteryl ester transfer protein (CETP) inhibition as a therapeutic strategy.

Membership Software Powered by YourMembership  ::  Legal